Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Pharmacology Research & Perspectives|October 29, 2021
Long-term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamoxJoshua C Zamora, Hudson R Smith, Elaine M Jennings, et al.
Behavioural Pharmacology|August 10, 2022
OREX-1038: a potential new treatment for pain with low abuse liability and limited adverse effectsLisa R Gerak, David R Maguire, Gerta Cami-Kobeci, et al.
Journal of Medicinal Chemistry|April 26, 2014
Selectively promiscuous opioid ligands: discovery of high affinity/low efficacy opioid ligands with substantial nociceptin opioid peptide receptor affinityVinod Kumar, Irna E Ridzwan, Konstantinos Grivas, et al.
Molecular Pharmacology|May 28, 2015
Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and InternalizationJanet D Lowe, Helen S Sanderson, Alexandra E Cooke, et al.
British Journal of Pharmacology|November 27, 2020
A novel G protein-biased agonist at the μ opioid receptor induces substantial receptor desensitisation through G protein-coupled receptor kinaseSam Groom, Nina K Blum, Alexandra E Conibear, et al.
Journal of Medicinal Chemistry|February 27, 2013
Orvinols with mixed kappa/mu opioid receptor agonist activityBenjamin M Greedy, Faye Bradbury, Mark P Thomas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2018
Evaluation of 11C-BU99008, a PET Ligand for the Imidazoline2 Binding Site in Human BrainRobin J Tyacke, Jim F M Myers, Ashwin Venkataraman, et al.
ACS Chemical Neuroscience|April 7, 2015
Selectivity and anti-Parkinson's potential of thiadiazolidinone RGS4 inhibitorsLevi L Blazer, Andrew J Storaska, Emily M Jutkiewicz, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 29, 2021
The Buprenorphine Analogue BU10119 Attenuates Drug-Primed and Stress-Induced Cocaine Reinstatement in MiceTodd M Hillhouse, Keith M Olson, James E Hallahan, et al.
Biochemistry|December 22, 2004
Harmane and harmalan are bioactive components of classical clonidine-displacing substanceChristine A Parker, Neil J Anderson, Emma S J Robinson, et al.
Pageof 11